PMA device
Lutonix Drug Coated Balloon PTA Catheter
Lutonix · Drug-Coated Peripheral Transluminal Angioplasty Catheter (PRC, Class III) · First FDA decision Feb 26, 2018, newest Aug 29, 2024Kidney failure and dialysisPeripheral artery disease
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
PMA pathway
Device trials
655
Naming "Drug Coated"
MAUDE reports
2,970
Brand "Drug Coated", since 2015
PubMed studies
3,481
Mentioning "Drug Coated"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Lutonix Drug Coated Balloon PTA Catheter
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- Lutonix Drug Coated Balloon PTA CatheterPMA supplement
P170003-S026 · Decided Aug 29, 2024 · 539 days after receipt · Normal 180 Day Track
Device type: Drug-coated peripheral transluminal angioplasty catheter (PRC) · Cardiology
- Lutonix Drug Coated Balloon PTA CatheterPMA supplement
P170003-S024 · Decided Dec 16, 2021 · 83 days after receipt · Normal 180 Day Track No User Fee
Device type: Drug-coated peripheral transluminal angioplasty catheter (PRC) · Cardiology
- Lutonix Drug Coated BalloonPMA supplement
P170003-S001 · Decided Feb 26, 2018 · 154 days after receipt · Normal 180 Day Track No User Fee
Device type: Drug-coated peripheral transluminal angioplasty catheter (PRC) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with StentingNational analysisReview closedCAG-00085R8Updated Sep 21, 2026
- Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with StentingNational analysisReview closedCAG-00085R7Updated Sep 21, 2026
- Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with StentingNational analysisReview closedCAG-00085R6Updated Sep 21, 2026
- Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with StentingNational analysisReview closedCAG-00085R3Updated Sep 21, 2026
- Percutaneous Transluminal Angioplasty (PTA) and Stenting of the Renal ArteriesNational analysisReview closedCAG-00085R4Updated Sep 21, 2026
- Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with StentingNational analysisReview closedCAG-00085NUpdated Sep 15, 2026
- Percutaneous Transluminal Angioplasty (PTA)National determinationOn the books20.7Updated May 14, 2025
Clinical trials
Device studies on ClinicalTrials.gov that name "Drug Coated", any status and sponsor, newest update first.
- Rotational Atherectomy and Drug-Coated Balloon Angioplasty With Embolic Protection for Superficial Femoral Artery OcclusionsNot yet recruiting
Sakarya UniversityAcademic, hospital or other
NCT07803718 · 60 participants (planned) · Start Dec 1, 2026 · Primary completion Jun 1, 2028
Device: Rotational Atherectomy With Distal Embolic Protection and Drug-Coated Balloon Angioplasty · For: Peripheral Artery Disease; Atherectomy in Diseased Lower Extremity Arteries
Sites: Adapazarı, Turkey (Türkiye)
Attikon HospitalAcademic, hospital or other
NCT07858539 · 55 participants · Start Apr 1, 2025 · Primary completion Nov 17, 2026
Device: Laser atherectomy followed by Sirolimus-eluting balloon angioplasty of femoropopliteal or infrapopliteal or both arterial stenosis or occlusions · For: Chronic Limb Threatening Ischemia
Sites: Athens, Greece
- Comparison of Fractional FLOW Reserve Outcomes With Drug-Coated Balloon-Based Versus Drug-Eluting Stent-Only Percutaneous Coronary Intervention StrategiesPivotal-lookingRecruiting
Korea University Guro HospitalAcademic, hospital or other
NCT07852689 · 100 participants (planned) · Start Nov 16, 2026 · Primary completion Sep 30, 2028
Device: Drug-coated balloon-based intervention; Drug-eluting stent-based intervention · For: Coronary Artery Disease; Percutaneous Coronary Intervention; Drug Coated Balloon and 3 more
Sites: Seoul, South Korea · 4 sites in all
652 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Drug Coated", and for the whole product code for context.
This brand
2,970 reports: 423 malfunction, 2,117 injury, 430 death
Whole product code PRC
543 reports: 107 malfunction, 427 injury, 9 death
Newest reports for this brand
- Lutonix 018 Drug Coated Dilatation CatheterMalfunction
3006513822-2026-00038 · Received Oct 23, 2026 · Event dated Oct 3, 2026
Device type: Drug-Eluting Peripheral Transluminal Angioplasty Catheter (ONU)
Device problem as coded: Inflation Problem; Material Twisted/Bent
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
3006513822-2026-00037 · Received Oct 14, 2026 · Event dated Nov 20, 2022
Device type: Drug-Coated Peripheral Transluminal Angioplasty Catheter (PRC)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Hemorrhage/Blood Loss/Bleeding; Necrosis
Philips Image Guided Therapy Corporation
3016257349-2026-00016 · Received Oct 8, 2026 · Event dated Oct 18, 2024
Device type: Drug-Eluting Peripheral Transluminal Angioplasty Catheter (ONU)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Insufficient Information
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Drug Coated"[tiab]. The summary above synthesizes these.
- Indications for Use of Drug-Coated Balloons in Coronary Intervention: Academic Research Consortium Position Statement.
Fezzi S, Serruys PW, Cortese B, et al. · J Am Coll Cardiol · 2025Review, Consensus Statement
- Drug-coated balloon: It's debatable.
King Iii SB · Cardiovasc Revasc Med · 2026Editorial
- Drug-Coated Balloons in Small Vessels: Preferred Strategy to Drug-Eluting Stents?
Abbott JD, Wykrzykowska JJ, Lenselink C · JACC Cardiovasc Interv · 2023Editorial, Comment
- Coronary Drug-Coated Balloon Angioplasty: What Are the Next Steps?
Colleran R, Fitzgerald S, Byrne RA · JACC Cardiovasc Interv · 2023Editorial, Comment
- Definitions and standardized endpoints for the use of drug-coated balloon in coronary artery disease: consensus document of the Drug Coated Balloon Academic Research Consortium.
Fezzi S, Scheller B, Cortese B, et al. · Eur Heart J · 2025Consensus Statement
- Drug-Coated Balloons for Percutaneous Coronary Intervention: Does Coating Matter?
Mukherjee D, Mares AC · JACC Cardiovasc Interv · 2024Editorial, Comment
- Drug-Coated Balloon Angioplasty in Pulmonary Vein Stenosis: A Promising Tool.
Ghobrial J · JACC Case Rep · 2023Editorial
- Peripheral Drug-Coated Balloon for Coronary Drug-Eluting Stent In-Stent Restenosis: Off-Label, Off-Target.
Waksman R, Abusnina W · J Soc Cardiovasc Angiogr Interv · 2024Editorial
- Drug-coated balloons - Interest is building.
King SB · Cardiovasc Revasc Med · 2025Editorial
- Rethinking coronary artery metal implants.
Leone PP, Gitto M, Gao C, et al. · Prog Cardiovasc Dis · 2025Editorial
- Angioplasty with drug-coated balloon catheters: the coming tide?
Byrne RA, Durand R · EuroIntervention · 2024Editorial
- Drug-Coated Balloon for Long Femoropopliteal Lesions.
Banerjee S, Khalili H · Circ Cardiovasc Interv · 2018Editorial, Comment
Other devices of this type
Also filed under product code PRC.
- IN.PACT AV Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) BalloonMedtronic Vascular, Inc. · PMA 2024
- LUTONIX 035 Drug Coated Balloon PTA Catheter, Model 9010Lutonix · PMA 2019
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.